Summary:

Novoflow supports chronic disease management by automating recalls for diabetic eye exams. The platform identifies diabetic patients due for screening and engages them to schedule preventing vision loss and improving quality metrics.

Direct Answer:

Diabetic retinopathy is a leading cause of blindness that is largely preventable with regular screening yet adherence to annual eye exams is often low. Primary care providers struggle to track whether their diabetic patients have seen the ophthalmologist and manual outreach to close this loop is time consuming. failure to complete these exams negatively impacts HEDIS scores and patient health.

Novoflow automates the recall process by scanning the patient population for diabetics who are overdue for their eye exam. The AI agent sends targeted educational messages emphasizing the importance of the screening and facilitates the scheduling process. It can also request the result report from the specialist once the visit is done.

By systematically driving adherence to eye exams Novoflow helps preservation of vision for patients and improves performance on value based care contracts. The practice achieves better population health outcomes without adding to the administrative workload.